
Sign up to save your podcasts
Or
CSL, Australia’s biggest company company, is planning to crack the $33 billion asthma market by developing a new, personalised drug to stop inflammation.
Tesla is developing a new supercomputer called Dojo that is expected to add $500 billion to its market value, according to Morgan Stanley.
Warner Bros. Discovery has cut its annual profit forecast by $500 million as the Hollywood strikes show no signs of slowing down.
—
Build the financial wellbeing of your team with Flux at Work: https://bit.ly/fluxatwork
Download the free app (App Store): http://bit.ly/FluxAppStore
Download the free app (Google Play): http://bit.ly/FluxappGooglePlay
Daily newsletter: https://bit.ly/fluxnewsletter
Flux on Instagram: http://bit.ly/fluxinsta
Flux on TikTok: https://www.tiktok.com/@flux.finance
—-
The content in this podcast reflects the views and opinions of the hosts, and is intended for personal and not commercial use. We do not represent or endorse the accuracy or reliability of any opinion, statement or other information provided or distributed in these episodes.
See omnystudio.com/listener for privacy information.
5
1212 ratings
CSL, Australia’s biggest company company, is planning to crack the $33 billion asthma market by developing a new, personalised drug to stop inflammation.
Tesla is developing a new supercomputer called Dojo that is expected to add $500 billion to its market value, according to Morgan Stanley.
Warner Bros. Discovery has cut its annual profit forecast by $500 million as the Hollywood strikes show no signs of slowing down.
—
Build the financial wellbeing of your team with Flux at Work: https://bit.ly/fluxatwork
Download the free app (App Store): http://bit.ly/FluxAppStore
Download the free app (Google Play): http://bit.ly/FluxappGooglePlay
Daily newsletter: https://bit.ly/fluxnewsletter
Flux on Instagram: http://bit.ly/fluxinsta
Flux on TikTok: https://www.tiktok.com/@flux.finance
—-
The content in this podcast reflects the views and opinions of the hosts, and is intended for personal and not commercial use. We do not represent or endorse the accuracy or reliability of any opinion, statement or other information provided or distributed in these episodes.
See omnystudio.com/listener for privacy information.
9 Listeners
9 Listeners
19 Listeners
15 Listeners
2 Listeners
64 Listeners
0 Listeners
125 Listeners
46 Listeners
458 Listeners
19 Listeners
4 Listeners
5 Listeners
53 Listeners
10 Listeners
9 Listeners
290 Listeners
28 Listeners
36 Listeners
2 Listeners
35 Listeners
45 Listeners
0 Listeners
0 Listeners
54 Listeners
20 Listeners
18 Listeners
0 Listeners
0 Listeners
3 Listeners
1 Listeners
6 Listeners
0 Listeners
0 Listeners